Next generation of antimicrobials must be antibiofilms

Yannick Plétan


Dr.Yanick Plétan

CMO (acting), Medical & Clinical Strategy – MD, MSc, FFPM, Harvard Business School, HEC


At BioFilm Pharma, Yannick acts as CMO (non executive), in charge of the global strategy and the clinical trials.

With 30 years in the pharmaceutical industry Yannick was subsequently Head of Global Immunology R&D (Sanofi), Chief Medical Officer, Global Head of Development and of R&D Strategy (Pierre Fabre Research Institute) conducting the development and worldwide registration of several new molecular entities, VP-Head of Medical & Scientific Division (Pfizer SAS), Member of the Country Executive Committee, and for the past 5 years, Country Medical Director and a Member of the Global Medical Affairs Council Roche-Genentech). There he co-founded the Roche Research Institute for public-private partnerships and the Foundation for Personalized HealthCare in Strasbourg (France). In 2015, Yannick joined Ultrace, in the biotech sector, as Senior Medical Consultant in Health Care.

He co-authored peer reviewed publications (34), international guidelines (WHO, ICH), co-founded the European Diploma of Pharmaceutical Medicine and a private Master Degree for Pharma Industry physicians.

He is a board-certified pulmonologist and immunologist from the University of Paris with a Master Degree in Clinical Pharmacology and Pharmacokinetics.

As Clinical Assistant Professor of Respiratory Medicine, he held the Head of a Respiratory Medicine Department, with a fellow-researcher position at INSERM.